National Day Special | Guoke Information: Bringing Smart Testing to Life, with Digital Intelligence Pioneers Connecting the Entire Health Management Ecosystem

Today, the healthcare industry is accelerating into the deep waters of digital and intelligent transformation. Traditional healthcare IT solutions have largely focused on in-hospital closed-loop scenarios such as clinical diagnosis and treatment and departmental management, giving rise to numerous pain points—including limited service contexts, narrow user reach, and fragmented health‑care offerings. Meanwhile, public health needs have long transcended the confines of conventional medical care, shifting from disease‑centric treatment to comprehensive, full‑cycle health management that encompasses preventive care, ongoing monitoring, and post‑illness recovery. At the same time, demand for digitalization in specialized areas—such as occupational health screenings, routine physical‑examination monitoring, and precision laboratory quality control—is steadily increasing. The industry urgently requires an integrated digital health solution that seamlessly connects institutions, business operations, and individual users.

The value of healthcare digitalization lies not only in migrating offline processes online, but also in deeply understanding specialized clinical contexts, ensuring the orderly execution of complex workflows, and enabling information to deliver its full potential when needed. By aligning with the business needs of medical and health service institutions, the company has developed a product portfolio that provides mutual support.

In response to these challenges, Guoke Information has been continuously exploring the integrated development of healthcare informatization and digital health services. Grounded in specialized software and IT services, the company has gradually established… Three major product lines: the Laboratory Information System, the Health Examination and Occupational Health Management System, and the Laboratory Quality Management and Specialty Business Systems. 。 Laboratory Medicine Direction Covers third-party LIS, online report retrieval, WeChat-based services, and SPD supply chain management for laboratory reagents. Occupational Health Management in the Context of Medical Examinations Covering occupational health and routine medical examination services, with extended offerings in member engagement, WeChat-based services, self-service options, and intelligent triage. Quality and Specialty Division It encompasses a two-tier quality-control platform, imaging systems, and a pathology testing management system, with seamless front-to-back-end collaboration, to build a comprehensive digital product ecosystem tailored for medical laboratories, health check-up centers, and pathology institutions. And position the health‑focused digital human as a key strategic initiative for the future. , driving the expansion of services from business management within medical institutions to continuous personal health management.

This represents not only the iterative refinement of our product portfolio and the diversification of our product offerings, but also a long-term strategic decision rooted in the company’s commitment to the industry’s core essence and its focus on users’ fundamental needs—centered around the pivotal question of how technology can truly serve health. Unlike most players in the sector, who prioritize tool‑oriented software development and short‑term business implementation, we remain steadfastly grounded in the intrinsic value of health services. We eschew superficial, homogenized applications and instead ensure that digital and intelligent technologies are deployed in real‑world health‑care settings.

During the 2026 CACLP Conference, the 11th “Voice of Innovation” Annual Symposium on Laboratory Medicine and the 13th Forum on the Development of New Technologies in the In‑Vitro Diagnostics Industry were held with great fanfare. Renowned industry expert, Director Chen Falin, was invited to deliver a keynote address titled “The Impact of Mutual Recognition of Test Results on IVD,” offering an in-depth analysis of national policy directions, industry transformation trends, and pathways toward high‑quality development.

The report notes that, as the National Health Commission and six other departments jointly advance the implementation of policies promoting mutual recognition of laboratory test results, standardized quality control, end-to-end process management, and data interoperability have become central priorities for the IVD industry and the development of clinical laboratory testing. Mutual recognition of test results is not only a people‑centric policy that enhances public convenience but also serves as a critical measure to compel clinical laboratories to standardize quality control and inter‑laboratory proficiency testing. Building a robust clinical laboratory quality management platform has thus emerged as an essential quality‑control tool, applicable across multiple settings, including provincial and municipal clinical testing centers, regional testing hubs, medical consortia, and healthcare communities.

Director Chen Falin explicitly emphasized in his report that the clinical quality management platform, aligned with national quality‑control standards and mutual‑recognition policies, leverages digital, standardized, and intelligent technologies to deliver an integrated solution encompassing internal quality control, external proficiency testing, end-to-end quality monitoring, data interoperability and mutual recognition, and compliance management.

At this conference, authoritative voices once again underscored Guoke Information’s leading position and robust technological capabilities in IVD translation, intelligent quality control, and laboratory‑wide standardization.

After receiving your medical examination report, how should you interpret the specialized indicators it contains? What changes have occurred between this year’s results and last year’s? Which findings warrant ongoing monitoring? And when you encounter questions or concerns, how can you access professional support? These specific issues are precisely the starting point for the company’s strategic deployment of virtual digital humans.

BIOSINO joins hands with The Data Space Research Institute of the Hefei Comprehensive National Science Center has launched this project. , leveraging big data technology Seamlessly integrate end-to-end processes spanning precision diagnostics, health assessments, risk early warning, and personalized interventions, driving health management from “experience-based prevention” to “data‑driven precision empowerment.”

Digital human technology serves as the “terminal interface” of this ecosystem: by constructing a digital health profile for each user, it transforms multi-source diagnostic data into visualized health assessment reports. ; Through an AI-powered virtual health management assistant, we provide personalized services—ranging from risk alerts to intervention recommendations—for diverse populations. What we aim to address is, It’s not just about “how to present a report,” but rather about “how to help an individual continuously understand and stay engaged with their own health.”

The virtual digital humans being developed by the company are not merely static avatars for display or broadcasting; instead, they leverage personal health records, integrate AI‑driven interaction and digital visualization, and serve as a personalized gateway to health services. The product strategy centers on consolidating individual health data—gradually incorporating physical examination results, wearable device metrics, and other relevant information—to power health‑related Q&A, information presentation, and routine reminders. In line with this positioning, the product’s development is focused on three key areas.

Making health information easier to understand: By leveraging digital human models, organ-level visualizations, and simplified information presentation, we help users establish a more intuitive connection between professional reports and their own health, making complex data easier to access and understand.

Ensuring the continuity of health records: By organizing personal health records and comparing information across multiple assessments, a continuously updated health profile is gradually established. The focus extends beyond any single test result to encompass data from different time points and the trends in their changes.

Integrating health services into daily life: Guided by health‑knowledge Q&A, daily reminders, and ongoing engagement, we are exploring a service evolution—from “reviewing a report after a checkup” to “maintaining continuous health awareness in everyday life.” This also serves as the core rationale behind features such as health recommendations, customer Q&A, and periodic notifications in our product roadmap.

In this process, The digital avatar serves as the medium of expression, personal health data forms the foundation of the service, and sustained companionship is the long-term value the product aims to deliver.

Within the company’s overall strategic framework, medical informatics solutions and virtual digital humans are not separate, independent business lines; rather, they form an integrated ecosystem that serves both institutional and individual users, mutually reinforcing one another. Systems for health check-ups, occupational health, third-party laboratories, quality control, and pathology are anchored on the institutional side, providing robust IT support for specialized clinical workflows. Meanwhile, virtual digital humans target the consumer end, pioneering new ways to interpret, visualize, and deliver ongoing health‑related services.

Accordingly, the company aims to progressively establish a clear growth roadmap: positioning itself as a specialized provider of healthcare IT services, leveraging virtual digital humans to connect with individuals, expanding service reach through insurance partnerships, and addressing real-world needs with tailored health‑care offerings. The value of this strategic framework lies in fostering synergy across all stages, rather than merely increasing the sheer number of products.

For institutions, it represents the opportunity to extend professional services into everyday health management; for partners, it means co‑creating a more sustainable customer‑service model; and for individuals, it makes fragmented health data easier to interpret and subsequent care more seamlessly connected. For the company itself, this entails building out product operations, user support, and ecosystem‑collaboration capabilities—while maintaining its software‑development and project‑delivery expertise—thus pursuing a growth trajectory that evolves from delivering standalone systems to providing ongoing, value‑added services. Crucially, what requires sustained investment is not just user scale, but also domain‑specific expertise, standardized service workflows, superior product experiences, and the trust of both users and partners.